Femara vs Aromasin: Letrozole vs Exemestane | Dose Track
[Breast cancer · Aromatase inhibitor · Comparison]

Femara vs Aromasin: how do the two aromatase inhibitors differ?

Approved uses · Dose · Bone loss · Side effects

Short answer: Both are aromatase inhibitors for breast cancer in postmenopausal women.12 Femara (letrozole) 2.5 mg once a day can follow surgery directly, follow 5 years of tamoxifen, or treat advanced cancer. Aromasin (exemestane) 25 mg once daily after a meal follows 2 to 3 years of tamoxifen to complete 5 years, or treats advanced cancer after tamoxifen. Neither label reports a trial against the other.

How do Femara and Aromasin compare side by side?

From the US Femara and Aromasin labels. Each label compares its drug with tamoxifen in a different trial (BIG 1-98 and IES), so the two columns are not a head-to-head comparison.
FemaraAromasin
DrugLetrozole1Exemestane2
Early breast cancerAfter surgery, or as extended treatment after 5 years of tamoxifen1After 2 to 3 years of tamoxifen, switching to complete 5 years in total2
Advanced breast cancerFirst- or second-line treatment1After the cancer has progressed on tamoxifen2
Dose2.5 mg once a day with or without food; every other day with cirrhosis or severe liver impairment125 mg once daily after a meal; 50 mg with a strong CYP3A4 inducer2
Trial against tamoxifenBIG 1-98: high cholesterol 52.3% vs 28.6%, hot flashes 33.5% vs 38.0%, joint pain 25.4% vs 20.6%1IES: hot flushes 21% vs 20%, fatigue 16% vs 15%, joint pain 15% vs 9%2
Spine bone density vs tamoxifenMedian fall of 4.1% in 2 years vs a 0.3% rise1-3.1% at 24 months vs -0.2%2
Missed doseNo instruction in the label1No instruction in the label2
Boxed warningNone1None2

Reviewed . Half-life figures are shown only where the value Dose Track uses agrees with the cited source.

How do the warnings differ?

Both labels warn about bone loss, with bone density monitoring, and harm to an unborn baby: effective birth control for at least 3 weeks after the last Femara dose, and for 1 month after the last Aromasin dose.12 Femara adds raised cholesterol, tiredness and dizziness, and a lower dose with cirrhosis or severe liver impairment.1 Aromasin adds a vitamin D check before starting, no estrogen-containing medicines alongside it, and that it is not for women before menopause.2 These numbers come from separate trials with different people, lengths and methods, so they are not a head-to-head comparison.

Which, if either, fits is for your prescriber. More detail: Femara side effects, Aromasin side effects, the Femara and Aromasin dosing schedules, the Femara missed-dose page, Anastrozole vs letrozole: what is the difference? and Anastrozole vs exemestane: how do these aromatase inhibitors differ?.

Frequently asked questions

Are Femara and Aromasin the same kind of drug?+
Yes. Both labels describe them as aromatase inhibitors, approved for breast cancer in postmenopausal women.12
Are they used after tamoxifen?+
Both can be. Femara is approved as extended treatment after 5 years of tamoxifen; Aromasin is used after 2 to 3 years of tamoxifen to complete 5 years in total.12
What if I miss a dose?+
Neither label gives a missed-dose instruction, so ask your prescriber or pharmacist.12
Can Dose Track remind me to take them?+
Yes. You can log each dose and set a reminder.